CNS drugs approved by the centralised European procedure

True innovation or dangerous stagnation?

Corrado Barbui, Andrea Cipriani, Camilla Lintas, Vittorio Bertelé, Silvio Garattini

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)265-268
Number of pages4
JournalPsychopharmacology
Volume190
Issue number2
DOIs
Publication statusPublished - Feb 2007

ASJC Scopus subject areas

  • Pharmacology

Cite this

CNS drugs approved by the centralised European procedure : True innovation or dangerous stagnation? / Barbui, Corrado; Cipriani, Andrea; Lintas, Camilla; Bertelé, Vittorio; Garattini, Silvio.

In: Psychopharmacology, Vol. 190, No. 2, 02.2007, p. 265-268.

Research output: Contribution to journalArticle

@article{e878996ff55a4b98959dcd3e47449327,
title = "CNS drugs approved by the centralised European procedure: True innovation or dangerous stagnation?",
author = "Corrado Barbui and Andrea Cipriani and Camilla Lintas and Vittorio Bertel{\'e} and Silvio Garattini",
year = "2007",
month = "2",
doi = "10.1007/s00213-006-0629-3",
language = "English",
volume = "190",
pages = "265--268",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - CNS drugs approved by the centralised European procedure

T2 - True innovation or dangerous stagnation?

AU - Barbui, Corrado

AU - Cipriani, Andrea

AU - Lintas, Camilla

AU - Bertelé, Vittorio

AU - Garattini, Silvio

PY - 2007/2

Y1 - 2007/2

UR - http://www.scopus.com/inward/record.url?scp=33845765623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845765623&partnerID=8YFLogxK

U2 - 10.1007/s00213-006-0629-3

DO - 10.1007/s00213-006-0629-3

M3 - Article

VL - 190

SP - 265

EP - 268

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -